NOUSCOM AG
4Patents
4Active
4Granted
44Portfolio score
Filing activity: Jul 5, 2018 → Nov 2, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11643666B2 | Eukaryotic cell line | Emerging Cross-Sectional Technologies | 1 | Active |
| US11578109B2 | Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers | Human Necessities | 0 | Active |
| US11098324B2 | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11912743B2 | Compositition and uses of teleost invariant chain to enhance T cell response to a vaccine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.